Intervention Protocol

Rilpivirine versus efavirenz for initial therapy in treatment-naive, HIV-1-infected patients

  1. Adeniyi Oluwaseun Ogunjale1,*,
  2. Charles I Okwundu2

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 18 JAN 2014

Assessed as up-to-date: 22 DEC 2013

DOI: 10.1002/14651858.CD010935


How to Cite

Ogunjale AO, Okwundu CI. Rilpivirine versus efavirenz for initial therapy in treatment-naive, HIV-1-infected patients (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010935. DOI: 10.1002/14651858.CD010935.

Author Information

  1. 1

    Stellenbosch University, Communty Health Division, Faculty of Medicine and Health Sciences, Tygerberg, South Africa

  2. 2

    Stellenbosch University, Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Tygerberg, South Africa

*Adeniyi Oluwaseun Ogunjale, Communty Health Division, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa. ogunjaleniyi@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 18 JAN 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the effectiveness of rilpivirine compared to efavirenz as first-line treatment in patients with HIV infection.